Human angiotensin I-converting enzyme gene and endurance performance

被引:287
作者
Myerson, S
Hemingway, H
Budget, R
Martin, J
Humphries, S
Montgomery, H
机构
[1] UCL, Rayne Inst, Dept Cardiovasc Genet, Ctr Cardiovasc Genet, London WC1E 6JJ, England
[2] Royal Free Hosp, Sch Med, Rayne Inst, London WC1E 6JJ, England
[3] UCL, Dept Epidemiol & Publ Hlth Med, London WC1E 6BT2, England
[4] Northwick Pk Hosp & Clin Res Ctr, British Olymp Med Ctr, Harrow HA1 3UJ, Middx, England
关键词
exercise; angiontensin I-converting enzyme genotype; polymorphism;
D O I
10.1152/jappl.1999.87.4.1313
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Human physical performance is strongly influenced by genetic factors. A variation in the structure of the human angiotensin I-converting enzyme (ACE) gene has been reported in which the insertion (I) variant is associated with lower ACE levels than the deletion (D) gene. We have previously reported that the I variant was associated with improved endurance performance in high-altitude mountaineers and British Army recruits. We now examine this genotype distribution in 91 British Olympic-standard runners (79 Caucasians). DNA was extracted from the buccal cells contained in 10 mi of saline mouthwash donated by the subjects, and the I and D variants of the ACE gene were identified by PCR amplification of the polymorphic region. There was an increasing frequency of the I allele with distance run [0.35, 0.53, and 0.62 for less than or equal to 200 m (n = 20), 400-3,000 m (n = 37), and greater than or equal to 5,000 m (n = 34), respectively; P = 0.009 for linear trend]. Among 404 Olympic-standard athletes from 19 other mixed sporting disciplines (in which endurance performance was not necessarily a key factor), the I allele did not differ significantly from that found in control subjects: 0.50 vs. 0.49 (P = 0.526). These results support a positive association of the I allele with elite endurance performance.
引用
收藏
页码:1313 / 1316
页数:4
相关论文
共 33 条
[1]  
BARLEY J, 1994, J HYPERTENS, V12, P955
[2]   ANGIOTENSIN-II AND LEFT-VENTRICULAR GROWTH IN NEWBORN PIG-HEART [J].
BEINLICH, CJ ;
WHITE, GJ ;
BAKER, KM ;
MORGAN, HE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1991, 23 (09) :1031-1038
[3]   Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism [J].
Brink, M ;
Wellen, J ;
Delafontaine, P .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2509-2516
[4]   BRADYKININ PEPTIDES IN KIDNEY, BLOOD, AND OTHER TISSUES OF THE RAT [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1993, 21 (02) :155-165
[5]   Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London [J].
Cappuccio, FP ;
Cook, DG ;
Atkinson, RW ;
Strazzullo, P .
HEART, 1997, 78 (06) :555-563
[6]   ANGIOTENSIN-I-CONVERTING ENZYME IN HUMAN CIRCULATING MONONUCLEAR-CELLS - GENETIC-POLYMORPHISM OF EXPRESSION IN LYMPHOCYTES-T [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
LOPEZ, M ;
ALHENCGELAS, F .
BIOCHEMICAL JOURNAL, 1993, 290 :33-40
[7]  
DANSER AHJ, 1995, CIRCULATION, V62, P1387
[8]   STIMULATION OF GLYCOGENOLYSIS IN HEPATOCYTES BY ANGIOTENSIN-II MAY INVOLVE BOTH CALCIUM RELEASE AND CALCIUM INFLUX [J].
DEWITT, LM ;
PUTNEY, JW .
FEBS LETTERS, 1983, 160 (1-2) :259-263
[9]   THE KALLIKREIN-KININ SYSTEM AND MUSCLE METABOLISM - BIOCHEMICAL ASPECTS [J].
DIETZE, G ;
WICKLMAYR, M ;
BOTTGER, I ;
SCHIFMANN, R ;
GEIGER, R ;
FRITZ, H ;
MEHNERT, H .
AGENTS AND ACTIONS, 1980, 10 (04) :335-338
[10]  
DRAGOVIC T, 1996, DIABETES S, V1, pS34